Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTItm (milsaperidone) tablets, a first line therapy for the acute treatment of manic or ...
The Federal Ministry of Education has opened applications for the recruitment of Technical Facilitators for Federal Technical Colleges nationwide. The ...